Colagrande S, Calistri L, Campani C, Dragoni G, et al. CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib. Eur Radiol 2021;31:1608-1619.
PMID: 32827266